UPLOAD Filing
Vor Biopharma Inc.
Date: Sept. 30, 2025 · CIK: 0001817229 · Accession: 0000000000-25-010639
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290490
Letter
September 30, 2025 Jean-Paul Kress, M.D. President and Chief Executive Officer Vor Biopharma Inc. 500 Boylston Street, Suite 1350 Boston, Massachusetts 02116 Re:Vor Biopharma Inc. Registration Statement on Form S-3 Filed September 24, 2025 File No. 333-290490 Dear Jean-Paul Kress M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Katie Kazem
Show Raw Text
September 30, 2025
Jean-Paul Kress, M.D.
President and Chief Executive Officer
Vor Biopharma Inc.
500 Boylston Street, Suite 1350
Boston, Massachusetts 02116
Re:Vor Biopharma Inc.
Registration Statement on Form S-3
Filed September 24, 2025
File No. 333-290490
Dear Jean-Paul Kress M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Katie Kazem